Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) When Co-administered With High Dose of Atorvastatin in Patients With Primary Hypercholesterolemia
PHASE2
Primary Objective:
To evaluate the effect of alirocumab (SAR236553/REGN727...
Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of Statin
PHASE3
Primary Objective:
To demonstrate the reduction of low-density lipoprotein...
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin
PHASE2
This study investigates the safety, pharmacokinetics and effects of GSK1292...